PHGUF (Pharming Group) Days Payable : 309.10 (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Pharming Group Days Payable?

Pharming Group's average Accounts Payable for the three months ended in Dec. 2024 was $41.4 Mil. Pharming Group's Cost of Goods Sold for the three months ended in Dec. 2024 was $12.2 Mil. Hence, Pharming Group's Days Payable for the three months ended in Dec. 2024 was 309.10.

The historical rank and industry rank for Pharming Group's Days Payable or its related term are showing as below:

PHGUF' s Days Payable Range Over the Past 10 Years
Min: 131.4 Med: 177.4 Max: 488.95
Current: 488.95

During the past 13 years, Pharming Group's highest Days Payable was 488.95. The lowest was 131.40. And the median was 177.40.

PHGUF's Days Payable is ranked better than
77.73% of 705 companies
in the Biotechnology industry
Industry Median: 122.62 vs PHGUF: 488.95

Pharming Group's Days Payable declined from Dec. 2023 (503.57) to Dec. 2024 (309.10). It may suggest that Pharming Group accelerated paying its suppliers.

Pharming Group Days Payable Historical Data

The historical data trend for Pharming Group's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharming Group Days Payable Chart

Pharming Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Payable

Get a 7-Day Free Trial

419.57

181.88

169.93

179.34

134.69

Pharming Group Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Payable	Get a 7-Day Free Trial															503.57	459.94	808.82	974.22	309.10

Competitive Comparison of Pharming Group's Days Payable

For the Biotechnology subindustry, Pharming Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharming Group's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharming Group's Days Payable distribution charts can be found below:

* The bar in red indicates where Pharming Group's Days Payable falls into.

Save Embed

;

Save Embed

;

Pharming Group Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Pharming Group's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (16.022	+	10.103)	/	2 )	/	35.399	*	365
=	13.0625					/	35.399	*	365
=	134.69

Pharming Group's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

	Days Payable (Q: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2024 )	+	Accounts Payable (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (72.638	+	10.103)	/	2 )	/	12.213	*	365 / 4
=	41.3705					/	12.213	*	365 / 4
=	309.10

Pharming Group Days Payable Related Terms

Thank you for viewing the detailed overview of Pharming Group's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharming Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharming Group (OTCPK:PHGUF) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

PHAR:USA PHARM:Netherlands 0QCO:UK PHG:Germany PHGN:Germany

Address

Darwinweg 24, Leiden, ZH, NLD, 2333 CR

Website

https://www.pharming.com

Pharming Group is a biopharmaceutical company. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome. In addition, the firm's development pipeline includes KL1333, a potential first-in-disease asset for mitochondrial DNA-driven primary mitochondrial diseases. The company's reportable segments are RUCONEST, which derives maximum revenue, Joenja, U.S., and Europe and the Rest of the World (RoW). Geographically, it derives maximum revenue from the United States.